Asthma and PM10 |
| |
Authors: | Kenneth Donaldson M Ian Gilmour William MacNee |
| |
Institution: | 1. Istituto di Fisiopatologia Respiratoria, Consiglio Nazionale delle Ricerche, Via Trabucco, Palermo, Italia 2. Institut National de la Santé et de la Recherche Médicale U454, CHU de Montpellier, France
|
| |
Abstract: | Glucocorticoids (GCs) are routinely used as anti-inflammatory drugs in the treatment of asthma. They act through binding to glucocorticoid receptor α (GRα), which represses numerous genes encoding pro-inflammatory mediators. A hormone binding deficient GR isoform named GRβ has been isolated in humans. When overexpressed by transfection, GRβ may function as a dominant negative modulator of GRα. However, to act as such, GRβ has to be more abundant than GRα, and conflicting data have been obtained concerning the relative levels of the two isoforms in cell lines and freshly isolated cells. Moreover, the dominant negative effect was not confirmed by independent laboratories. In GC-resistant asthmatics, GRβ was expressed by an increased number of peripheral blood mononuclear cells (PBMCs), airway T cells, and cells found in skin biopsies of tuberculin responses. However, the relative amounts of GRα and GRβ in these cells were not determined. In GC-dependent asthmatics, PBMCs expressed GRα predominantly. No cells containing higher levels of GRβ than GRα have yet been reported in asthmatics. Even if the existence of such cells is demonstrated, the role of GRβ in asthma will remain a matter of controversy because functional studies have given discrepant data. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|